Vol 5, No 6 (December 27, 2016): Chinese Clinical Oncology

Original Article

Metallothionein 2A an interactive protein linking phosphorylated FADD to NF-κB pathway leads to colorectal cancer formation
Faiz M. M. T. Marikar, Guanghui Jin, Wang Sheng, Dingyuan Ma, Zichun Hua
A prospective, multicenter phase II trial of low-dose erlotinib as maintenance treatment after platinum doublet chemotherapy for advanced non-small cell lung cancer harboring EGFR mutation
Satoshi Hirano, Go Naka, Yuichiro Takeda, Motoyasu Iikura, Noriko Hayama, Asako Yanagisawa, Hiroyuki Amano, Makoto Nakamura, Sukeyuki Nakamura, Hiroshi Tabeta, Haruhito Sugiyama
An efficient method for native protein purification in the selected range from prostate cancer tissue digests
Rumana Ahmad, Carrie D. Nicora, Anil K. Shukla, Richard D. Smith, Wei-Jun Qian, Alvin Y. Liu
Transdermal granisetron for the prevention of nausea and vomiting following moderately or highly emetogenic chemotherapy in Chinese patients: a randomized, double-blind, phase III study
Liu-Qing Yang, Xin-Chen Sun, Shu-Kui Qin, Ying-Xia Chen, He-Long Zhang, Ying Cheng, Zhen-Dong Chen, Jian-Hua Shi, Qiong Wu, Yu-Xian Bai, Bao-Hui Han, Wei Liu, Xue-Nong Ouyang, Ji-Wei Liu, Zhi-Hui Zhang, Yong-Qiang Li, Jian-Ming Xu, Shi-Ying Yu

Disclosure:

1. The series “Statistics in Oncology Clinical Trials” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Daniel J. Sargent and Qian Shi served as the unpaid Guest Editors for the series.

2. The series “Meet the Professor” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding.